Filing Details

Accession Number:
0000875320-23-000043
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-11-21 16:07:18
Reporting Period:
2023-11-20
Accepted Time:
2023-11-21 16:07:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1223348 Jr F Charles Wagner C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Evp & Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-11-20 3,000 $349.88 46,693 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1, which was entered into on 08/18/2023.
  2. Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
  3. Open market sales reported on this line occurred at a weighted average price of $349.88 (range $349.76 to $350.00).